Revefenacin
Revefenacin
Revefenacin (pronounced as rev-eh-fen-a-cin) is a type of bronchodilator used in the treatment of chronic obstructive pulmonary disease (COPD). It is marketed under the brand name Yupelri.
Etymology
The name Revefenacin is derived from its chemical structure. The "rev" refers to its reverse amide linkage, "efe" refers to its ether and phenyl groups, and "nacin" refers to its quinuclidinyl xanthene carboxylate moiety.
Usage
Revefenacin is used as a maintenance treatment for patients with COPD, including chronic bronchitis and emphysema. It is not used for the relief of acute bronchospasm or for the treatment of asthma.
Mechanism of Action
Revefenacin is a long-acting muscarinic antagonist (LAMA). It works by blocking the action of acetylcholine on muscarinic receptors in the lung, leading to bronchodilation.
Side Effects
Common side effects of Revefenacin include cough, nasopharyngitis, upper respiratory tract infection, headache, and back pain. Serious side effects may include allergic reactions and worsening of narrow-angle glaucoma or urinary retention.
Related Terms
- Bronchodilator
- Chronic obstructive pulmonary disease
- Chronic bronchitis
- Emphysema
- Muscarinic antagonist
- Acetylcholine
External links
- Medical encyclopedia article on Revefenacin
- Wikipedia's article - Revefenacin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski